{"id":"https://openalex.org/W4387572114","doi":"https://doi.org/10.1111/trf.310_17554","title":"P\u2010PH\u20105 | Qualification of High Titer COVID\u201019 Convalescent Plasma with an Anti\u2010SARS\u2010CoV\u20102 IgG Quantitative Test","display_name":"P\u2010PH\u20105 | Qualification of High Titer COVID\u201019 Convalescent Plasma with an Anti\u2010SARS\u2010CoV\u20102 IgG Quantitative Test","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387572114","doi":"https://doi.org/10.1111/trf.310_17554"},"language":"en","primary_location":{"id":"doi:10.1111/trf.310_17554","doi":"https://doi.org/10.1111/trf.310_17554","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1111/trf.310_17554","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.310_17554","source":{"id":"https://openalex.org/S186746772","display_name":"Transfusion","issn_l":"0041-1132","issn":["0041-1132","0372-1248","1537-2995","1878-2000"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transfusion","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.310_17554","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044760785","display_name":"Paul Contestable","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Contestable","raw_affiliation_strings":["QuidelOrtho"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QuidelOrtho","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066612829","display_name":"Clara Di Germanio","orcid":"https://orcid.org/0000-0002-6047-211X","observed_orcids":["https://orcid.org/0000-0002-6047-211X"]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Di Germanio","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044091762","display_name":"Eduard Grebe","orcid":"https://orcid.org/0000-0001-7046-7245","observed_orcids":["https://orcid.org/0000-0001-7046-7245"]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Grebe","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054359071","display_name":"Mars Stone","orcid":"https://orcid.org/0000-0001-5619-2767","observed_orcids":["https://orcid.org/0000-0001-5619-2767"]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Stone","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068608033","display_name":"Graham Simmons","orcid":"https://orcid.org/0000-0002-9615-7023","observed_orcids":["https://orcid.org/0000-0002-9615-7023"]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Simmons","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111350975","display_name":"X. Deng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Deng","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067188451","display_name":"Marion C. Lanteri","orcid":"https://orcid.org/0000-0002-4213-5013","observed_orcids":["https://orcid.org/0000-0002-4213-5013","https://orcid.org/0009-0003-0855-7487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Lanteri","raw_affiliation_strings":["Creative Testing Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creative Testing Solutions","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021822340","display_name":"Valerie Green","orcid":"https://orcid.org/0000-0002-7101-3111","observed_orcids":["https://orcid.org/0000-0002-7101-3111"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Green","raw_affiliation_strings":["Creative Testing Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creative Testing Solutions","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062975649","display_name":"Michael Paul Busch","orcid":"https://orcid.org/0000-0002-1446-125X","observed_orcids":["https://orcid.org/0000-0002-1446-125X"]},"institutions":[{"id":"https://openalex.org/I4405258483","display_name":"Vitalant Research Institute","ror":"https://ror.org/00r2ye360","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210157777","https://openalex.org/I4405258483"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Busch","raw_affiliation_strings":["Vitalant Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vitalant Research Institute","institution_ids":["https://openalex.org/I4405258483"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":null,"fwci":0.2073,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51798524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"63","issue":"S5","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19-convalescent-plasma","display_name":"COVID-19 convalescent plasma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/neutralizing-antibody-titer","display_name":"neutralizing antibody titer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/breakthrough-infection","display_name":"breakthrough infection","score":0.7089999914169312},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.7799999713897705},{"id":"https://openalex.org/keywords/delta-variant","display_name":"Delta variant","score":0.9700000286102295},{"id":"https://openalex.org/keywords/vaccine-breakthrough-infection","display_name":"vaccine breakthrough infection","score":0.49799999594688416},{"id":"https://openalex.org/keywords/sars-cov-2-variants-of-concern","display_name":"SARS-CoV-2 variants of concern","score":0.8140000104904175},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.6809999942779541},{"id":"https://openalex.org/keywords/antibody-titer-thresholds","display_name":"antibody titer thresholds","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7486352324485779},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.7048760652542114},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.6359127163887024},{"id":"https://openalex.org/C2777267654","wikidata":"https://www.wikidata.org/wiki/Q3519023","display_name":"Test (biology)","level":2,"score":0.5240193605422974},{"id":"https://openalex.org/C3018027319","wikidata":"https://www.wikidata.org/wiki/Q420496","display_name":"Convalescent plasma","level":5,"score":0.51337730884552},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.4971809685230255},{"id":"https://openalex.org/C3018233652","wikidata":"https://www.wikidata.org/wiki/Q101965","display_name":"Experimental research","level":2,"score":0.41743218898773193},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.35964125394821167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31842824816703796},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2908518314361572},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23143014311790466},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2077871561050415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13549929857254028},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.13491922616958618},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.12678560614585876},{"id":"https://openalex.org/C145420912","wikidata":"https://www.wikidata.org/wiki/Q853077","display_name":"Mathematics education","level":1,"score":0.11509478092193604},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.08875671029090881},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/trf.310_17554","doi":"https://doi.org/10.1111/trf.310_17554","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1111/trf.310_17554","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.310_17554","source":{"id":"https://openalex.org/S186746772","display_name":"Transfusion","issn_l":"0041-1132","issn":["0041-1132","0372-1248","1537-2995","1878-2000"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transfusion","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1111/trf.310_17554","doi":"https://doi.org/10.1111/trf.310_17554","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1111/trf.310_17554","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.310_17554","source":{"id":"https://openalex.org/S186746772","display_name":"Transfusion","issn_l":"0041-1132","issn":["0041-1132","0372-1248","1537-2995","1878-2000"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transfusion","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387572114.pdf","grobid_xml":"https://content.openalex.org/works/W4387572114.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387577810","https://openalex.org/W4414160636","https://openalex.org/W4403197583","https://openalex.org/W3123972627","https://openalex.org/W3118448206","https://openalex.org/W4280488766","https://openalex.org/W3120947147","https://openalex.org/W4200353823","https://openalex.org/W3130000761","https://openalex.org/W4406053986"],"abstract_inverted_index":{"With":[0,225],"SARS-CoV-2":[1,91,120],"variants":[2,92],"challenging":[3],"COVID-19":[4,8,124],"monoclonal":[5],"antibody":[6,47,70,202],"therapies,":[7],"convalescent":[9],"plasma":[10,30,96],"(CCP)":[11],"remains":[12],"an":[13],"important":[14],"option":[15],"for":[16,23,178],"immunocompromised":[17],"patients.":[18],"Current":[19],"US":[20],"regulatory":[21],"criteria":[22],"qualifying":[24,45,230],"CCP":[25,229],"as":[26,207,209],"high":[27,215,340,378],"titer":[28],"requires":[29],"to":[31,67,157,165,347],"be":[32],"collected":[33,103,237],"from":[34,98,163,238,351],"symptomatic":[35,111,307,363],"individuals":[36,305],"within":[37],"6":[38],"months":[39],"of":[40,93,194,212,232,235,247,274,336,349,370,387],"diagnosis,":[41],"and":[42,84,107,112,133,136,181,200,221,253,263,268,283,292,297,313,319,321,383],"test":[43,62,160],"above":[44],"binding":[46],"levels":[48,71],"on":[49],"specific":[50],"authorized":[51,394],"anti-SARS-CoV-2":[52],"tests.":[53],"In":[54],"this":[55],"study,":[56],"the":[57,149,159,197,210,226,243,332],"Vitros\u00ae":[58],"Anti-SARS-CoV-2":[59],"IgG":[60],"Quantitative":[61],"(Vitros":[63],"IgGQ)":[64],"was":[65,88,301],"used":[66],"measure":[68],"spike-binding":[69],"in":[72,75,344,358],"serial":[73],"samples":[74,97,236],"repeat":[76],"blood":[77,101],"donors":[78,102,361],"who":[79],"were":[80,115,146,175,205,281],"infected":[81],"and/or":[82,154],"vaccinated,":[83],"their":[85],"neutralization":[86,186,191],"activity":[87,187],"characterized":[89],"against":[90,381],"concern.":[94],"Longitudinal":[95],"120":[99],"allogeneic":[100],"between":[104,196,304,360],"September":[105],"2020":[106],"December":[108],"2022,":[109],"including":[110],"asymptomatic":[113,309,365],"infections,":[114,310],"categorized":[116],"into":[117],"three":[118],"groups:":[119],"infection":[121,130],"followed":[122,127,139],"by":[123,128,140,395],"vaccination,":[125],"vaccination":[126,138],"breakthrough":[129,240],"during":[131,242,259,277,288],"Delta":[132,244,278],"Omicron":[134,260,289],"waves,":[135],"primary":[137],"a":[141,272,368],"booster":[142],"without":[143],"infection.":[144],"Samples":[145,174],"tested":[147],"with":[148,214,265,294,306,311,362,377],"Vitros":[150,198],"IgGQ":[151,199],"at":[152,218,316,324],"1:20":[153],"1:400":[155],"dilution,":[156],"increase":[158],"upper":[161],"range":[162],"200":[164],"either":[166],"4000":[167],"or":[168,308,364,389],"80000":[169],"Binding":[170],"Antibody":[171],"Units":[172],"(BAU)/mL*.":[173],"also":[176],"quantified":[177],"ancestral":[179,382],"(D614G)":[180],"variant-specific":[182],"(Beta,":[183],"Delta,":[184],"Omicron)":[185],"(reporter":[188],"viral":[189],"particle":[190],"assays).":[192],"Correlation":[193],"results":[195,359],"neutralizing":[201],"(nAb)":[203],"titers":[204,217,251,266,295,342,380],"evaluated,":[206],"well":[208],"percent":[211],"donations":[213,248,350,376],"nAb":[216,250,341,379],">200":[219,233,317,337],"BAU/mL":[220,223,318,338,372],">4000":[222,275,325,371],"thresholds.":[224],"current":[227,333],"FDA-defined":[228],"threshold":[231,273,335,369],"BAU/mL,":[234,276,326],"vaccine":[239],"infections":[241,258,287],"wave":[245,279],"61.7%":[246],"had":[249],">1:250":[252,282,315,323],"51.1%":[254],">":[255],"1:500.":[256],"Breakthrough":[257,286],"yielded":[261,290],"80.5%":[262],"73.4%":[264],">250":[267,296],">500,":[269,298],"respectively.":[270,299,327],"Using":[271,367],"96.7%":[280],"92.2%":[284],">1:500.":[285],"97.4%":[291],"94.7%":[293],"There":[300,354],"no":[302,356],"difference":[303,357],"57.8%":[312],"58.7%":[314],"96.6%":[320],"100%":[322],"This":[328],"study":[329],"demonstrates":[330],"that":[331],"FDA":[334],"yields":[339],"(>1:500)":[343],"only":[345],"~51%":[346],"73%":[348],"infected/vaccinated":[352],"donors.":[353],"is":[355],"infections.":[366],"would":[373],"yield":[374],">92%":[375],"variant":[384],"viruses":[385],"regardless":[386],"infection/vaccination":[388],"timing":[390],"status.":[391],"*dilution":[392],"not":[393],"FDA.":[396]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-10-13T00:00:00"}